SCHEMBL9101495

SCHEMBL9101495

COCC(=O)NC1CCC(NC(=O)c2c(C)[nH]c3c(-c4cc(OC)c(F)cc4OCC4CC4)ccnc23)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 8/20 0.36
CCNT1 O60563 6/20 0.36
CASP3 P42574 1/20 0.36
CASP7 P55210 1/20 0.36
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
PDE4B Q07343 2/20 0.35
PDE4D Q08499 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KCNH2 Q12809 1/20 0.34
LDHA P00338 1/20 0.34
PRKACA P17612 1/20 0.34
PRKACG P22612 1/20 0.34
PRKACB P22694 1/20 0.34
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9104221 1.00 CDK9 (0.36) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9101486 1.00 CDK9 (0.36) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9105731 0.97 CDK9 (0.36) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9101397 0.97 CDK9 (0.36) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9101392 0.97 CDK9 (0.36) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9102014 0.93 CDK9 (0.41) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9101600 0.93 CDK9 (0.37) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9101595 0.93 CDK9 (0.37) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9104441 0.93 CDK9 (0.37) CDK9CCNT1CASP3CASP7CDK1
SCHEMBL9102004 0.93 CDK9 (0.41) CDK9CCNT1CASP3CASP7CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8816085-B2 Methylpyrrolopyridinecarboxamides TAKEDA GMBH (DE) 2014-08-26 US claimed
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-07 US claimed
US-8816085-B2 Methylpyrrolopyridinecarboxamides TAKEDA GMBH (DE) 2014-08-26 US disclosed
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A CDK9 1048/4885CCNT1 1888/4885CASP3 966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.